Intra-Cellular
Intra-Cellular Therapies is a biopharmaceutical company founded on research that uncovered how therapies affect the inner-working of cells in the human body.
Business Model:
Revenue: $188.1M
Employees: 501-1,000
Industries / Tags:
Detailed Intra-Cellular Information
Geographic Data
Address: 430 East 29th Street
City: New York
State: NY
Zip: 10016
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$150M
Raised Total:$674M
Social
Metrics
2,054,074Website Global Rank
8,892Website Monthly Traffic
Twitter Followers
Description
Intra-Cellular Therapies is a biopharmaceutical company founded on research that uncovered how therapies affect the inner-working of cells in the human body.
Contact Phone:
+16464409333
Contact Email:
Intra-Cellular went public on 2/14/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/14/2014
Ticker Symbol:
ITCI
IPO Price:
$16.67766644119411/share
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Post-IPO Equity | $150M | 9/2013 | IPO | $139.5M | 3/2015 | Post-IPO Equity | $121.4M | 1/2022 | Post-IPO Equity | $460M | 9/2015 | Post-IPO Equity | $327.4M | 5/2013 | Debt Financing | $15.3M | 9/2013 | Secondary Market | 2 | $60M |
Deepfield Broadfin Capital Deepfield Broadfin Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
